There is a critical need for sensitive, highly specific immunoassays of clinical samples using minimal sample volume. Advances in microfluidic systems enable the sensitive quantitation of proteins in a small sample volume by using parallel detection systems. In contrast to multiplexing, this parallel approach prevents cross-reactivities of detection antibodies and negative effects on sensitivity of the assays. This live webinar brings together a panel of experts to discuss how they are validating immunoassays for clinical use.

Topics to be covered:

  • Case studies highlighting the validation of analytes, including cytokine and angiogenic markers
  • Assay testing of plasma and ocular fluids
  • Oncology and ophthalmology applications of clinical immunoassays

Meet the Speakers:

Dr. Marianne Manchester
Head, Immunoassay and Metabolites Lab
Roche Innovation Center Basel

 

 

Dr. Martina Thier
Head, Immunoassay Lab
Roche Innovation Center Basel

 

 

Isabelle Wey
Technician, Immunoassay Lab
Roche Innovation Center Basel

 

Protein Simple
 

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?